Barriers to and strategies to address COVID-19 testing hesitancy: a rapid scoping review.
Barriers to and strategies to address COVID-19 testing hesitancy: a rapid scoping review.
复制标题
DOI：
10.1186/s12889-022-13127-7
复制
发表时间：
2022-04-14
影响因子：
4.5
通讯作者：
Tricco, Andrea
中科院分区：
文献类型：
--
作者：
Embrett, Mark;Sim, S. Meaghan;Caldwell, Hilary A. T.;Boulos, Leah;Yu, Ziwa;Agarwal, Gina;Cooper, Rhiannon;Gallant, Allyson J. A. J.;Bielska, Iwona A.;Chishtie, Jawad;Stone, Kathryn;Curran, Janet;Tricco, Andrea
关键词：
检测是任何COVID-19管理策略的基本组成部分;然而，新出现的证据表明，COVID-19检测的障碍和犹豫可能会影响接受或参与，而且这些往往是多个交叉因素，可能因人群而异。为此，加拿大卫生部的COVID-19检测和筛查专家咨询小组于2021年1月委托进行了此次快速审查，以探索该领域的现有证据。此次快速审查的目的是确定COVID-19检测的障碍以及用于缓解这些障碍的策略。在MEDLINE、Scopus、medRxiv/bioRxiv、科克伦和在线灰色文献来源中进行了检索（于2021年1月8日完成），以识别描述与COVID-19检测相关的障碍和策略的出版物。从1294篇学术文献和97篇灰色文献检索结果中，纳入31篇学术文献和31篇灰色文献。数据摘自相关论文。最常见的障碍是检测成本;健康素养低;对医疗保健系统的信任度低;检测地点的可用性和可及性;以及检测阳性的耻辱和后果。减少COVID-19检测障碍的策略包括：免费检测;提高对检测重要性的认识;介绍各种检测方案和检测中心类型（即，免下车、步行、家庭测试）;提供到测试中心的交通;以及提供对自我隔离的支持（例如，工资补贴或住房）。本集团已识别COVID-19测试的各种障碍及减轻这些障碍的策略。需要进一步研究以测试这些策略的有效性，以通过解决作为更广泛的COVID-19公共卫生应对措施的一部分的检测犹豫来更好地支持COVID-19检测。 在线版本包含补充材料，可通过10.1186/s12889-022-13127-7获得。
Testing is a foundational component of any COVID-19 management strategy; however, emerging evidence suggests that barriers and hesitancy to COVID-19 testing may affect uptake or participation and often these are multiple and intersecting factors that may vary across population groups. To this end, Health Canada’s COVID-19 Testing and Screening Expert Advisory Panel commissioned this rapid review in January 2021 to explore the available evidence in this area. The aim of this rapid review was to identify barriers to COVID-19 testing and strategies used to mitigate these barriers. Searches (completed January 8, 2021) were conducted in MEDLINE, Scopus, medRxiv/bioRxiv, Cochrane and online grey literature sources to identify publications that described barriers and strategies related to COVID-19 testing. From 1294 academic and 97 grey literature search results, 31 academic and 31 grey literature sources were included. Data were extracted from the relevant papers. The most cited barriers were cost of testing; low health literacy; low trust in the healthcare system; availability and accessibility of testing sites; and stigma and consequences of testing positive. Strategies to mitigate barriers to COVID-19 testing included: free testing; promoting awareness of importance to testing; presenting various testing options and types of testing centres (i.e., drive-thru, walk-up, home testing); providing transportation to testing centres; and offering support for self-isolation (e.g., salary support or housing). Various barriers to COVID-19 testing and strategies for mitigating these barriers were identified. Further research to test the efficacy of these strategies is needed to better support testing for COVID-19 by addressing testing hesitancy as part of the broader COVID-19 public health response. The online version contains supplementary material available at 10.1186/s12889-022-13127-7.
登录
查看更多内容
影响因子：
2.7
作者：
Galaviz KI;Breland JY;Sanders M;Breathett K;Cerezo A;Gil O;Hollier JM;Marshall C;Wilson JD;Essien UR
通讯作者：
Essien UR
影响因子：
3
作者：
Earnshaw, Valerie A.;Brousseau, Natalie M.;Fox, Annie B.
通讯作者：
Fox, Annie B.
DOI：
10.4269/ajtmh.20-1045
发表时间：
2020-11
期刊：
The American journal of tropical medicine and hygiene
影响因子：
--
作者：
Adebisi YA;Alaran AJ;Akinokun RT;Micheal AI;Ilesanmi EB;Lucero-Prisno DE
通讯作者：
Lucero-Prisno DE
影响因子：
3.4
作者：
Cordes, Jack;Castro, Marcia C.
通讯作者：
Castro, Marcia C.
DOI：
10.1016/j.sapharm.2020.03.007
发表时间：
2021-01-01
影响因子：
3.9
作者：
Amariles, Pedro;Ledezma-Morales, Monica;Hincapie-Garcia, Jaime Alejandro
通讯作者：
Hincapie-Garcia, Jaime Alejandro